REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/06/2026
Voltar para busca
Dado oficial do USPTO
AGILEX BIOLABS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
29/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
05/06/2020
Data de registro
29/06/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/06/2021
Última transação
29/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
82
Localização do titular
AU
Examinador
GLASSER, CARYN
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Agilex Biolabs Pty Ltd
Representantes
David L. May Nixon Peabody LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Advisory services relating to biochemistry; advisory services relating to pharmacology; advisory services relating to product testing; advisory services relating to sciencenamely consulting services in the field of bioanalytics; advisory services relating to scientific research; analysis of materialsnamely bioanalytical services; analytical laboratory services; biochemistry research services; biochemistry servicesnamely biochemistry research services; biological research; biotechnological research; biotechnology research; biotechnology testing in the field of bioanalytics; development of testing methods for clinical trials; conducting clinical trials FOR OTHERS; consultancy pertaining to pharmacology; laboratory analysis in the field of bioanalytics; laboratory research relating to bioanalytics; medical research laboratory services; laboratory services being scientific research or analysis; laboratory testing services in the field of bioanalytics; medical research; pharmaceutical research services; preparation of reports relating to scientific research; provision of information relating to scientific research in the field of bioanalytics; product quality testing; research laboratories in the field of bioanalytics; scientific research relating to biotechnology; scientific research relating to medicine; scientific research relating to pharmaceuticals; scientific and technical analysis in the field of bioanalytics; scientific research consultancy in the field of bioanalytics; scientific laboratory services in the field of bioanalytics; scientific research; scientific testing services in the field of bioanalytics; testing services for assessing the efficiency of pharmaceuticals; testing services for assessing the safety of pharmaceuticals; testing of products
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/11/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/10/2021
FIMP
FINAL DISPOSITION PROCESSED
27/10/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
29/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/04/2021
PUBO
PUBLISHED FOR OPPOSITION
13/04/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/04/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
24/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/02/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/02/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
19/02/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/02/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/02/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/02/2021
RFNT
REFUSAL PROCESSED BY IB
25/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/10/2020
RFRR
REFUSAL PROCESSED BY MPU
03/10/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/09/2020
CNRT
NON-FINAL ACTION WRITTEN
15/09/2020
DOCK
ASSIGNED TO EXAMINER
08/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
28/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/07/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/07/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AGILEX BIOLABS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.